NCT06069544 - A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria | Biotech Hunter

Enrollment

163

Participants

Timeline

Start Date

November 13, 2023

Primary Completion Date

May 28, 2025

Study Completion Date

March 31, 2026

Conditions

Malaria

Interventions

BIOLOGICAL

BNT165e

Multi-antigen RNA-based vaccine for active immunization against malaria administered as intramuscular injection

OTHER

Placebo

Isotonic NaCl solution (0.9%)

Trial Locations (5)

University of Maryland, Center for Vaccine Development, Baltimore

AMR Knoxville, Knoxville

Clinical Trials of Texas, San Antonio

AMR Tempe, Tempe

AMR Las Vegas, Las Vegas